Concepedia

Hyerin Yim

HY

Statistics

Publications

5

Citations

367

H-Index

5

Active since

2020

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of North Carolina at Chapel Hill

Hyerin Yim is an author at Icahn School of Medicine at Mount Sinai specializing in biochemistry, life sciences, and molecular oncology.

ORCID

Publications per year

2020–2024

5

Publications

5

Harnessing the E3 Ligase KEAP1 for Targeted Protein Degradation

Jieli Wei, Fanye Meng, Kwang‐Su Park et al. · Journal of the American Chemical Society · 2021 · 140 citations · Full text

, , +15

Bridged Proteolysis Targeting Chimera (PROTAC) Enables Degradation of Undruggable Targets

Yan Xiong, Yue Zhong, Hyerin Yim et al. · Journal of the American Chemical Society · 2022 · 129 citations · Full text

, , +16

Discovery of the First-in-Class G9a/GLP Covalent Inhibitors

Kwang‐Su Park, Yan Xiong, Hyerin Yim et al. · Journal of Medicinal Chemistry · 2022 · 45 citations · Full text

, , +17

Potent and Selective Mitogen-Activated Protein Kinase Kinase 1/2 (MEK1/2) Heterobifunctional Small-molecule Degraders

Jianping Hu, Jieli Wei, Hyerin Yim et al. · Journal of Medicinal Chemistry · 2020 · 42 citations · Full text

, , +17

Discovery of the First-in-Class G9a/GLP PROTAC Degrader

Julia Velez, Yulin Han, Hyerin Yim et al. · Journal of Medicinal Chemistry · 2024 · 11 citations · Full text

, , +15

1–5 of 5